Drug profile

The FDA adverse-event record for Nutraceutical Joint Supplement

62 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Nutraceutical Joint Supplement. See the species affected, top reactions, and outcomes below.

62
adverse-event reports
6.5%
death-coded share
Dog
most-reported species
13
Diarrhoea - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
62
Total Reports
4
Deaths Reported
6.5%
Death Rate

Active Ingredients

Nutraceutical Joint Supplement

Administration Routes

UnknownOralOther

Species Affected

Dog 54
Cat 8

Most Affected Breeds

Retriever - Labrador 18
Domestic Shorthair 5
Collie - Border 3
Spitz - German Pomeranian 3
Crossbred Canine/dog 3
Dog (unknown) 3
Retriever - Golden 2
Spaniel - Cocker English 2
Pointing Dog - German Short-haired 2
Spaniel - King Charles Cavalier 2

Most Reported Reactions

Diarrhoea 13
Vomiting 9
Anorexia 6
Abnormal radiograph finding 6
Lack of efficacy - NOS 6
Decreased appetite 5
Not eating 5
Lack of efficacy (endoparasite) - roundworm NOS 5
Nausea 4
Anaemia NOS 4
Emesis (multiple) 4
Lethargy (see also Central nervous system depression in Neurological) 4

Outcome Breakdown

Outcome Unknown
25 (40.3%)
Ongoing
23 (37.1%)
Recovered/Normal
10 (16.1%)
Died
2 (3.2%)
Euthanized
2 (3.2%)

Nutraceutical Joint Supplement Adverse Event Insights

62 reports name Nutraceutical Joint Supplement; 4 recorded a death outcome (6.5% of reported events, not a population-level mortality rate). Active ingredient: Nutraceutical Joint Supplement. Administration routes: Unknown, Oral, Other.

By species: Dog (54 reports), Cat (8 reports). By breed: Retriever - Labrador (18), Domestic Shorthair (5), Collie - Border (3).

Leading clinical signs: Diarrhoea (13), Vomiting (9), Anorexia (6), Abnormal radiograph finding (6). Outcome, 62 coded reports: Outcome Unknown leads at 40.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.